Kuroda Fuminobu, Moss Joel, Vaughan Martha
Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1434, USA.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3201-6. doi: 10.1073/pnas.0611696104. Epub 2007 Feb 21.
Brefeldin A-inhibited guanine nucleotide-exchange proteins (GEPs) BIG1 and BIG2 activate ADP-ribosylation factor (ARF) GTPases, which are required for vesicular trafficking. Both molecules contain one or more sites for binding protein kinase A, i.e., A kinase-anchoring protein (AKAP) sequences. Elevation of cell cAMP caused PKA-catalyzed phosphorylation and nuclear accumulation of BIG1 but not BIG2. We then asked whether BIG1 phosphorylation altered its GEP activity. Incubation of BIG1 or BIG2 with PKA catalytic subunits and ATP resulted in retardation of their electrophoretic migration, consistent with PKA phosphorylation. Okadaic acid inhibits many protein phosphatases, including protein phosphatase 1 (PP1) and PP2A, that can reverse PKA-catalyzed phosphorylation. Incubation of HepG2 cells with okadaic acid caused concentration-dependent accumulation of presumably phosphorylated BIG1 and BIG2 with decreased mobility, which was increased by subsequent incubation in vitro with specific recombinant phosphatases, PP1gamma > PP2A >> PP1alpha. For assays of GEP activity, BIG1 and BIG2 were immunoprecipitated from cells that had been depleted, respectively, of BIG2 and BIG1 by using specific siRNA. GEP activity of each was significantly decreased after incubation with recombinant PKA plus ATP and restored by incubation with PP1gamma. In agreement with a role for PP1gamma in regulation of BIG, endogenous PP1gamma, but not PP1alpha or beta, was immunoprecipitated with BIG1 or BIG2 from microsomal fractions. All observations are consistent with the effects of BIG1 and BIG2 phosphorylation on vesicular trafficking, via alterations in ARF activation and regulatory roles for cAMP, PKA, and PP1gamma in ARF activation by BIG1 and BIG2.
布雷菲德菌素A抑制的鸟嘌呤核苷酸交换蛋白(GEP)BIG1和BIG2可激活ADP核糖基化因子(ARF)GTP酶,而这是囊泡运输所必需的。这两种分子都含有一个或多个与蛋白激酶A结合的位点,即A激酶锚定蛋白(AKAP)序列。细胞内cAMP升高导致PKA催化BIG1磷酸化并使其在细胞核中积累,但BIG2没有这种现象。然后我们探究BIG1磷酸化是否改变其GEP活性。将BIG1或BIG2与PKA催化亚基及ATP一起孵育,导致其电泳迁移速率减慢,这与PKA磷酸化一致。冈田酸可抑制许多蛋白磷酸酶,包括蛋白磷酸酶1(PP1)和PP2A,它们可逆转PKA催化的磷酸化。用冈田酸孵育HepG2细胞会导致推测的磷酸化BIG1和BIG2浓度依赖性积累,迁移率降低,随后在体外与特异性重组磷酸酶PP1γ > PP2A >> PP1α一起孵育可使其增加。为了检测GEP活性,分别使用特异性siRNA从细胞中免疫沉淀出已被耗尽BIG2和BIG1的BIG1和BIG2。与重组PKA加ATP孵育后,每种的GEP活性均显著降低,而与PP1γ孵育后可恢复。与PP1γ在BIG调节中的作用一致,从微粒体组分中用BIG1或BIG2免疫沉淀出内源性PP1γ,但没有PP1α或β。所有观察结果均与BIG1和BIG2磷酸化通过改变ARF激活以及cAMP、PKA和PP1γ在BIG1和BIG2激活ARF中的调节作用对囊泡运输产生的影响一致。